Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
REGEnLIFE cures inflammatory brain diseases with light
Brain photobiomodulation: a potential treatment in Alzheimer’s and Parkinson’s diseases
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups

The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis

12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019, San Diego

Guillaume Blivet, Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Jacques Touchon.

Share this article